Background and objective Hidradenitis suppurativa (HS) is a chronic, progressive inflammatory disease with a substantial impact on quality of life. Accessibility to specialized units and referral methods may significantly influence clinical characteristics and therapeutic decisions. […]
Background/objective There is no consensus on the response rates of secukinumab, as findings from phase III trials differ from those reported in clinical-practice studies. This study aimed to assess the mid-term safety and efficacy profile […]
Background Recurrent aphthous stomatitis (RAS) and Behçet’s disease (BD) are part of the Behçet spectrum disorders (BSD), sharing genetic traits and characterized by recurrent ulcers. No systemic treatment is approved for RAS or incomplete BD, […]
Background The safety and efficacy profile of dupilumab in the management of atopic dermatitis (AD) are established in clinical trials. However, long-term real-world persistence data in Spain are limited. Objective The primary endpoint of the […]
The training of medical residents requires educational strategies that foster the comprehensive development of clinical, communication, and professional competencies. In this context, 360-degree evaluations have emerged as an alternative to traditional assessment methods, enabling a […]
Introducción La incidencia de cáncer de mama (CM) en mujeres jóvenes ha aumentado, pero existen pocos estudios que analicen factores pronósticos en este grupo etario. Métodos Estudio retrospectivo de pacientes con CM en etapas I–III, […]
Alzheimer’s disease (AD) is currently the leading cause of dementia among older adults. Indeed, this multifactorial neurodegenerative disease accounts for approximately 60-70% of all dementia cases among adults aged 80 years and older. Over the […]
El aumento sostenido de la carga global de cáncer, con proyecciones que superan los 35 millones de casos nuevos hacia 2050, junto con la creciente complejidad de los tratamientos oncológicos, ha posicionado al Químico Farmacéutico […]